New from our lab: Eosinophil activation is associated with cleavage of IL-5Rα to form soluble IL-5Rα - a biomarker for eosinophil activation and an inhibitor of IL-5 on eosinophils, suggesting it is a potential drug target for eosinophilic asthma.
academic.oup.com/ajrccm/advance…
academic.oup.com/ajrccm/advance…